Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

PURPOSE: To improve stratification of risk-adapted treatment for non-metastatic (M0), standard-risk medulloblastoma patients by prospective evaluation of biomarkers of reported biological or prognostic significance, alongside clinico-pathological variables, within the multi-center HIT-SIOP-PNET4 tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Clifford, Steven C., Lannering, Birgitta, Schwalbe, Ed C., Hicks, Debbie, O' Toole, Kieran, Nicholson, Sarah Leigh, Goschzik, Tobias, zur Mühlen, Anja, Figarella-Branger, Dominique, Doz, François, Rutkowski, Stefan, Gustafsson, Göran, Pietsch, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770740/
https://www.ncbi.nlm.nih.gov/pubmed/26420814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770740/
https://www.ncbi.nlm.nih.gov/pubmed/26420814

Ejemplares similares